Questions?
Contact Us
SYNERGY™ Bioabsorbable Polymer Stent: Designed to heal, the SYNERGY BP Stent has excellent clinical results. In 9 studies of more than 18,000 patients, SYNERGY BP Stent has shown outstanding safety with consistently low ST rates.

SYNERGY™
Bioabsorbable Polymer Stent


Designed to heal, the SYNERGY BP Stent has excellent clinical results. In 9 studies of more than 18,000 patients, SYNERGY BP Stent has shown outstanding safety with consistently low ST rates.

Promus PREMIER™ Permanent Polymer Stent: Promus PREMIER features the first customized Platinum Chromium Stent architecture, the market-leading Everolimus drug and PVDF-HFP polymer combination, and an enhanced catheter to provide PREMIER outcomes.

Promus PREMIER™ Permanent Polymer Stent


Promus PREMIER features the first customized Platinum Chromium Stent architecture, the market-leading Everolimus drug and PVDF-HFP polymer combination, and an enhanced catheter to provide PREMIER outcomes.

Promus PREMIER™ Permanent Polymer Stent: Promus PREMIER features the first customized Platinum Chromium Stent architecture, the market-leading Everolimus drug and PVDF-HFP polymer combination, and an enhanced catheter to provide PREMIER outcomes.

Agent™ Drug Coated Eluting Balloon


The AGENT™ Drug Coated Balloon catheter, built on the Emerge™ PTCA Balloon Catheter for exceptional deliverability, and its innovative TransPax™ coating technology, provides a targeted, therapeutic dose of proven, anti-proliferative Paclitaxel to the lesion. It is indicated to treat in-stent restenosis (ISR) and de novo / small vessel disease.*

EXPLORE THE BOSTON SCIENTIFICINTERVENTIONAL CARDIOLOGY PORTFOLIO

Join the Complex PCI Community


Join the Complex PCI Community to receive emails ...
and drug delivery systems. More than 3,000 HCPs in Europe have already confirmed.

REQUEST A REP


Want to keep the conversation going? Tell us a bit about yourself, and one of our representatives will reach out.

Top